France· FR:61110397

CEFEPIME TAMRISA 2 g, poudre pour solution injectable (IV)

A cefepime product containing dichlorhydrate de céfépime monohydraté, registered in France by TAMRISA ACCESS (FRANCE), on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J01DE01

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dichlorhydrate de céfépime monohydratéAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefepime is registered in 17 of 19 countries.

Countries holding a registration under ATC J01DE01 (cefepime), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
10 of them publish a price we can compare per daily dose

Search cefepime products by name

Cefepime · ATC J01DE01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefepime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefepime · price per daily dose (4 g)

USD · FX 28 Sept 2026

ES Spain$33.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: DICHLORHYDRATE DE CÉFÉPIME MONOHYDRATÉ
Manufacturer: TAMRISA ACCESS (FRANCE)
Country: France (FR)
ATC code: J01DE01
ATC class: Cefepime
Defined daily dose: 4 g, P
Reimbursed: Yes
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 2

1 priced

cip13
3400927322853
1 flacon(s) en verre
EUR 10.66
cip13
3400927323164
10 flacon(s) en verre

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

189 interactions on record for cefepime.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefepime against other medicines How interaction checks work

Cefepime · interactions on record

189 records

19 moderate
170 info

Most severe, free to view

Sodium picosulfateA06AB08moderate
NeomycinA07AA01moderate
StreptomycinA07AA04moderate
KanamycinA07AA08moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefepime in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefepime products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Cefepim Aptapharma, Cefepim Mip
Belgium · Cefepim Fresenius Kabi, Céfépime Ldp-Laboratorios Torlan
Bulgaria · Алфацеф, Бактерипим
Cyprus · Cefepim Noridem, Cefepime Aptapharma
Czechia · Cefepim Mip, Cefepim Noridem
Germany · Cefepim Accord, Cefepim Mip
Denmark · Cefepim Mip
Estonia · Alphacef, Cefepime Mip
Spain · Cefepima Kabi, Cefepima Ldp-Laboratorios Torlan
Finland · Cefepim Mip Pharma
Greece · Anticepim, Cefepime /Kabi
Croatia · Cefepim Aptapharma, Cefepime Kabi
Hungary · Cefepim Aptapharma, Cefepim Noridem
Italy · Cefepime Noridem, Cefepime Qilu
Lithuania · Cefepime Mip, Cefepime Norameda
Luxembourg · Cefepime Noridem
Latvia · Cefepime Mip, Cefepime Norameda
Malta · Cefepime Aptapharma
Netherlands · Cefepim Fresenius Kabi, Cefepim Noridem
Norway · Cefepim Mip
Poland · Cefepim Mip Pharma, Cefepime Aptapharma
Portugal · Cefepima Accord, Cefepima Basi
Romania · Cefepimă Aptapharma, Cefepimă Mip
Sweden · Cefepim Mip
Slovenia · Cefepim Aptapharma, Cefepim Kabi
Slovakia · Cefepim Mip, Cefepím Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b38e49d6-8a21-42bc-8e8a-b33264507fc2
GET /v1/drugs/b38e49d6-8a21-42bc-8e8a-b33264507fc2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61110397",
  "date_amm": "2013-05-23",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "DICHLORHYDRATE DE CÉFÉPIME MONOHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about cefepime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console